Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Amesite Inc.AMST · Entity 8151 | Director | September 30, 2024 | October 02, 2024 |
| Amesite Inc.NONE · Entity 149985 | Director | April 27, 2018 | May 01, 2018 |
| Blue Laser Fusion, Inc.NONE · Entity 107871 | Director · General Counsel and Secretary | September 04, 2026 | September 09, 2026 |
| Palomino Laboratories Inc.PALX · Entity 9910 | Director · Secretary | July 31, 2026 | August 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Amesite Inc.
Report date September 30, 2024 · Filed October 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 46,032 |
Reported balance
After 2024-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-09-30 · Grant · Acquired 4,898 · Balance 46,032 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share.
F2: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control.
Amesite Inc.
Report date April 27, 2018 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 41,667 |
Reported balance
After 2018-04-27 transaction · row 1
1 source rowRow 1 · 2018-04-27 · Purchase · Acquired 41,667 · Balance 41,667 |
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnote | 66,667 |
Reported balance
After 2018-04-27 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-04-27 · Purchase · Acquired 25,000 · Balance 66,667 F1: Includes 25,000 shares of common stock held of record by OGAWA Professional Corporation. The reporting person is the beneficial owner of OGAWA Professional Corporation and has voting and investment power over the securities held by OGAWA Professional Corporation. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 25,000 shares of common stock held of record by OGAWA Professional Corporation. The reporting person is the beneficial owner of OGAWA Professional Corporation and has voting and investment power over the securities held by OGAWA Professional Corporation.
Blue Laser Fusion, Inc.
Report date September 04, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 575,508 |
Ending reported balance
After 2026-09-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-04 · Grant · Acquired 568,235 · Balance 568,235 F1: Received in exchange for 900,000 shares of common stock (including 150,000 restricted shares of common stock) of Blue Laser Subsidiary Inc. (f/k/a Blue Laser Fusion Inc., "Pre-Merger BLF") in connection with the merger of Blue Laser Fusion Acquisition Co., a subsidiary of the issuer, with and into Pre-Merger BLF (the "Merger") pursuant to the Agreement and Plan of Merger, dated September 4, 2026. Row 2 · 2026-09-04 · Other · Acquired 7,273 · Balance 575,508 F2: Pursuant to a subscription agreement, simultaneously with the closing of the Merger, the Reporting Person purchased 7,273 shares of common stock of the issuer in a private placement offering at a price per share of $27.50. |
Filing footnotes · ownership attribution and instrument terms
F1: Received in exchange for 900,000 shares of common stock (including 150,000 restricted shares of common stock) of Blue Laser Subsidiary Inc. (f/k/a Blue Laser Fusion Inc., "Pre-Merger BLF") in connection with the merger of Blue Laser Fusion Acquisition Co., a subsidiary of the issuer, with and into Pre-Merger BLF (the "Merger") pursuant to the Agreement and Plan of Merger, dated September 4, 2026.
F2: Pursuant to a subscription agreement, simultaneously with the closing of the Merger, the Reporting Person purchased 7,273 shares of common stock of the issuer in a private placement offering at a price per share of $27.50.
Palomino Laboratories Inc.
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,882,500 |
Reported balance
After 2026-07-31 transaction · row 1
1 source rowRow 1 · 2026-07-31 · Other · Acquired 120,000 · Balance 1,882,500 F1: Pursuant to the terms of a certain Share Exchange Agreement and Plan of Reorganization, dated as of July 31, 2026, by and among Palomino Laboratories Inc. (the "Purchaser"), Vega Links, Inc. ("VLI") and the stockholders as listed on Schedule A attached thereto (the "Stockholders"), the Stockholders, who directly owned one hundred percent (100%) of the shares of VLI (the "Shares"), sold all the Shares to the Purchaser in exchange for 4,472,000 shares of the common stock, par value $0.0001 per share of the Purchaser ("Purchaser Stock"). As part of this transaction, Richard Ogawa, as a shareholder of VLI, received 120,000 shares of Purchaser Stock in exchange for his 300,000 shares of VLI. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of a certain Share Exchange Agreement and Plan of Reorganization, dated as of July 31, 2026, by and among Palomino Laboratories Inc. (the "Purchaser"), Vega Links, Inc. ("VLI") and the stockholders as listed on Schedule A attached thereto (the "Stockholders"), the Stockholders, who directly owned one hundred percent (100%) of the shares of VLI (the "Shares"), sold all the Shares to the Purchaser in exchange for 4,472,000 shares of the common stock, par value $0.0001 per share of the Purchaser ("Purchaser Stock"). As part of this transaction, Richard Ogawa, as a shareholder of VLI, received 120,000 shares of Purchaser Stock in exchange for his 300,000 shares of VLI.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INPHI Corp
Report date April 20, 2021 · Filed April 20, 2021
Section 16 reporting ended · disclosed 2021-04-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 98,448 |
Reported balance
After 2021-04-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-04-20 · Grant · Acquired 20,456 · Balance 98,448 F1: On April 20, 2021, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 29, 2020 (the "Merger Agreement") by and among by and among Marvell Technology Group Ltd., a Bermuda exempted company ("Marvell"), Marvell Technology, Inc. (f/k/a Maui HoldCo, Inc.), a Delaware corporation and a wholly owned subsidiary of Marvell ("HoldCo"), Maui Acquisition Company Ltd, a Bermuda exempted company and a wholly owned subsidiary of HoldCo ("Bermuda Merger Sub"), Indigo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of HoldCo ("Delaware Merger Sub"), and Inphi Corporation, a Delaware corporation ("Inphi"), Bermuda Merger Sub merged with and into Marvell with Marvell as the surviving corporation and a wholly owned subsidiary of Holdco (the "Bermuda Merger"), F2: (continued from footnote 1) and Delaware Merger Sub merged with and into Inphi with Inphi as the surviving corporation and a wholly owned subsidiary of Holdco (the "Delaware Merger" and, together with the Bermuda Merger, the "Mergers"). At the effective time of the Mergers, the restricted stock units that vest based on the per share market value of the shares of Inphi Common Stock (the "Inphi Common Stock") exceeding certain relative performance target levels (a "MVSU") were vested in full on April 20, 2020. The holder of such vested MVSUs became entitled to receive (subject to applicable withholding or other taxes) (i) an amount in cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU, and (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU. |
| Common StockSEC Table I · non-derivative | Direct | 42,218 |
Reported balance
After 2021-04-20 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-04-20 · Disposition to issuer · Disposed 56,230 · Balance 42,218 F3: Disposed pursuant to the Merger Agreement, whereby at the effective time of the Mergers, the outstanding Inphi Common Stock was automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.00 in cash, without interest (in addition to cash in lieu of fractional shares). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2021-04-20 · Disposition to issuer · Disposed 42,218 · Balance 0 F4: Per the terms of the Merger Agreement, (a) 35,025RSUs that were outstanding and vested immediately prior to the effective time of the Mergers (including 26,397 RSUs that only vest subject to delivery of an effective release) were cancelled in exchange for (subject to applicable withholding or other taxes), (i) an amount of cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, and (b) 7,307 RSUs were forfeited. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 20, 2021, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 29, 2020 (the "Merger Agreement") by and among by and among Marvell Technology Group Ltd., a Bermuda exempted company ("Marvell"), Marvell Technology, Inc. (f/k/a Maui HoldCo, Inc.), a Delaware corporation and a wholly owned subsidiary of Marvell ("HoldCo"), Maui Acquisition Company Ltd, a Bermuda exempted company and a wholly owned subsidiary of HoldCo ("Bermuda Merger Sub"), Indigo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of HoldCo ("Delaware Merger Sub"), and Inphi Corporation, a Delaware corporation ("Inphi"), Bermuda Merger Sub merged with and into Marvell with Marvell as the surviving corporation and a wholly owned subsidiary of Holdco (the "Bermuda Merger"),
F2: (continued from footnote 1) and Delaware Merger Sub merged with and into Inphi with Inphi as the surviving corporation and a wholly owned subsidiary of Holdco (the "Delaware Merger" and, together with the Bermuda Merger, the "Mergers"). At the effective time of the Mergers, the restricted stock units that vest based on the per share market value of the shares of Inphi Common Stock (the "Inphi Common Stock") exceeding certain relative performance target levels (a "MVSU") were vested in full on April 20, 2020. The holder of such vested MVSUs became entitled to receive (subject to applicable withholding or other taxes) (i) an amount in cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU, and (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU.
F3: Disposed pursuant to the Merger Agreement, whereby at the effective time of the Mergers, the outstanding Inphi Common Stock was automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.00 in cash, without interest (in addition to cash in lieu of fractional shares).
F4: Per the terms of the Merger Agreement, (a) 35,025RSUs that were outstanding and vested immediately prior to the effective time of the Mergers (including 26,397 RSUs that only vest subject to delivery of an effective release) were cancelled in exchange for (subject to applicable withholding or other taxes), (i) an amount of cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, and (b) 7,307 RSUs were forfeited.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 9, 2026 15:17 UTC | Blue Laser Fusion, Inc. NONE · Entity 107871 | OtherCommon Stock | 7,273 | $27.50 | $200,007.50 |
DisclosureSEC source: 0001493152-26-041922 · ownership.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 575,508 F2 · kind: Pursuant to a subscription agreement, simultaneously with the closing of the Merger, the Reporting Person purchased 7,273 shares of common stock of the issuer in a private placement offering at a price per share of $27.50. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 15:17 UTC | Blue Laser Fusion, Inc. NONE · Entity 107871 | GrantCommon Stock | 568,235 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-26-041922 · ownership.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 568,235 F1 · price: Received in exchange for 900,000 shares of common stock (including 150,000 restricted shares of common stock) of Blue Laser Subsidiary Inc. (f/k/a Blue Laser Fusion Inc., "Pre-Merger BLF") in connection with the merger of Blue Laser Fusion Acquisition Co., a subsidiary of the issuer, with and into Pre-Merger BLF (the "Merger") pursuant to the Agreement and Plan of Merger, dated September 4, 2026. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 19:50 UTC | Palomino Laboratories Inc. PALX · Entity 9910 | OtherCommon Stock | 120,000 | $5.14 | $616,800.00 |
DisclosureSEC source: 0001493152-26-035982 · ownership.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · Director · Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,882,500 F1 · kind: Pursuant to the terms of a certain Share Exchange Agreement and Plan of Reorganization, dated as of July 31, 2026, by and among Palomino Laboratories Inc. (the "Purchaser"), Vega Links, Inc. ("VLI") and the stockholders as listed on Schedule A attached thereto (the "Stockholders"), the Stockholders, who directly owned one hundred percent (100%) of the shares of VLI (the "Shares"), sold all the Shares to the Purchaser in exchange for 4,472,000 shares of the common stock, par value $0.0001 per share of the Purchaser ("Purchaser Stock"). As part of this transaction, Richard Ogawa, as a shareholder of VLI, received 120,000 shares of Purchaser Stock in exchange for his 300,000 shares of VLI. Read SEC document |
| April 20, 2026 Filed Apr 20, 2026 21:01 UTC | Palomino Laboratories Inc. NONE · Entity 9910 | PurchaseCommon Stock | 12,500 | $4.00 | $50,000.00 |
DisclosureSEC source: 0001493152-26-018119 · ownership.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · Director · Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,762,500 Read SEC document |
| September 29, 2025 Filed Oct 9, 2025 19:34 UTC | Palomino Laboratories Inc. NONE · Entity 9910 | SaleWarrants · Derivative | 125,000 | $1.20 Strike: $1.50 | $150,000.00 |
DisclosureSEC source: 0001493152-25-017571 · ownership.xml · derivative · entry 2 Ogawa Richard · CIK 0001568078 · Director · Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F1 · kind: Per the terms of an Agreement and Plan of Merger , dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Ogawa, as a shareholder of Pre-Merger Palomino, received 1,500,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Ogawa converted his SAFEs into 125,000 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). F1 · derivative.expiration_date: Per the terms of an Agreement and Plan of Merger , dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Ogawa, as a shareholder of Pre-Merger Palomino, received 1,500,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Ogawa converted his SAFEs into 125,000 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). Read SEC document |
| September 29, 2025 Filed Oct 9, 2025 19:34 UTC | Palomino Laboratories Inc. NONE · Entity 9910 | OtherCommon Stock | 1,625,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-017571 · ownership.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · Director · Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750,000 F1 · kind: Per the terms of an Agreement and Plan of Merger , dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Ogawa, as a shareholder of Pre-Merger Palomino, received 1,500,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Ogawa converted his SAFEs into 125,000 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). F1 · price: Per the terms of an Agreement and Plan of Merger , dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Ogawa, as a shareholder of Pre-Merger Palomino, received 1,500,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Ogawa converted his SAFEs into 125,000 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 23:13 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-084768 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,032 Underlying: Common Stock · 4,898 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:54 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-058667 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,134 Underlying: Common Stock · 4,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 23:05 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 5,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-028990 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,134 Underlying: Common Stock · 5,381 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:39 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 36,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-004626 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,630 Underlying: Common Stock · 36,630 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The RSUs vest over one year, with 100% vesting on the first anniversary date of the grant. F2 · derivative.expiration_date: The RSUs vest over one year, with 100% vesting on the first anniversary date of the grant. Read SEC document |
| December 29, 2023 Filed Jan 4, 2024 00:16 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-000918 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,753 Underlying: Common Stock · 5,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:05 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001013762-23-001104 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,420 Underlying: Common Stock · 4,706 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:38 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 3,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-054887 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,714 Underlying: Common Stock · 3,324 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 01:53 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-027322 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,390 Underlying: Common Stock · 4,598 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F3 · balance_after: On February 21, 2023, a 1-for-12 reverse stock split of the common stock of AMST was effected, resulting in the reporting person's ownership of one-twelfth (1/12) of the number of RSUs owned prior to such reverse stock split. Read SEC document |
| December 30, 2022 Filed Jan 5, 2023 11:18 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 68,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-000977 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,504 Underlying: Common Stock · 68,571 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:10 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 49,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-061253 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,933 Underlying: Common Stock · 49,793 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:36 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 26,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-037351 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,140 Underlying: Common Stock · 26,087 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:49 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 84,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-017971 · ownership.xml · derivative · entry 3 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,211 Underlying: Common Stock · 84,211 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F4 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F4 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:49 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 175,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-017971 · ownership.xml · derivative · entry 2 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,439 Underlying: Common Stock · 175,439 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F3 · derivative.exercise_date: The RSUs vest over one year, with 100% vesting on the first anniversary date of the grant. F3 · derivative.expiration_date: The RSUs vest over one year, with 100% vesting on the first anniversary date of the grant. Read SEC document |
| March 31, 2022 Filed Jul 5, 2022 22:29 UTC Amendment | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 21,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-037340 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,053 Underlying: Common Stock · 21,053 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 00:17 UTC | Amesite Inc. AMST · Entity 8151 | PurchaseCommon Stock | 20,000 | $1.10 | $21,900.00 |
DisclosureSEC source: 0001213900-21-063451 · ownership.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,666 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.079 to $1.12. The reporting person undertakes to provide Amesite Inc., any security holder of Amesite Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 28, 2021 Filed Apr 4, 2022 23:49 UTC | Amesite Inc. AMST · Entity 8151 | GrantStock option (right to buy) · Derivative | 9,184 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001213900-22-017971 · ownership.xml · derivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,184 Underlying: Common Stock · 9,184 shares Expires 2031-09-27 F1 · derivative.exercise_date: The option fully vests on the one-year anniversary of the date of grant. Read SEC document |
| April 20, 2021 Filed Apr 20, 2021 20:16 UTC | INPHI Corp IPHI · Entity 140160 | Disposition to issuerCommon Stock | 42,218 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-016461 · doc4.xml · nonDerivative · entry 3 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · shares: Per the terms of the Merger Agreement, (a) 35,025RSUs that were outstanding and vested immediately prior to the effective time of the Mergers (including 26,397 RSUs that only vest subject to delivery of an effective release) were cancelled in exchange for (subject to applicable withholding or other taxes), (i) an amount of cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, and (b) 7,307 RSUs were forfeited. F4 · price: Per the terms of the Merger Agreement, (a) 35,025RSUs that were outstanding and vested immediately prior to the effective time of the Mergers (including 26,397 RSUs that only vest subject to delivery of an effective release) were cancelled in exchange for (subject to applicable withholding or other taxes), (i) an amount of cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, and (b) 7,307 RSUs were forfeited. F4 · balance_after: Per the terms of the Merger Agreement, (a) 35,025RSUs that were outstanding and vested immediately prior to the effective time of the Mergers (including 26,397 RSUs that only vest subject to delivery of an effective release) were cancelled in exchange for (subject to applicable withholding or other taxes), (i) an amount of cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, and (b) 7,307 RSUs were forfeited. Read SEC document |
| April 20, 2021 Filed Apr 20, 2021 20:16 UTC | INPHI Corp IPHI · Entity 140160 | Disposition to issuerCommon Stock | 56,230 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-016461 · doc4.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,218 F3 · shares: Disposed pursuant to the Merger Agreement, whereby at the effective time of the Mergers, the outstanding Inphi Common Stock was automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.00 in cash, without interest (in addition to cash in lieu of fractional shares). F3 · price: Disposed pursuant to the Merger Agreement, whereby at the effective time of the Mergers, the outstanding Inphi Common Stock was automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.00 in cash, without interest (in addition to cash in lieu of fractional shares). F3 · balance_after: Disposed pursuant to the Merger Agreement, whereby at the effective time of the Mergers, the outstanding Inphi Common Stock was automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.00 in cash, without interest (in addition to cash in lieu of fractional shares). Read SEC document |
| April 20, 2021 Filed Apr 20, 2021 20:16 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 20,456 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-016461 · doc4.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,448 F1 · price: On April 20, 2021, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 29, 2020 (the "Merger Agreement") by and among by and among Marvell Technology Group Ltd., a Bermuda exempted company ("Marvell"), Marvell Technology, Inc. (f/k/a Maui HoldCo, Inc.), a Delaware corporation and a wholly owned subsidiary of Marvell ("HoldCo"), Maui Acquisition Company Ltd, a Bermuda exempted company and a wholly owned subsidiary of HoldCo ("Bermuda Merger Sub"), Indigo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of HoldCo ("Delaware Merger Sub"), and Inphi Corporation, a Delaware corporation ("Inphi"), Bermuda Merger Sub merged with and into Marvell with Marvell as the surviving corporation and a wholly owned subsidiary of Holdco (the "Bermuda Merger"), F2 · price: (continued from footnote 1) and Delaware Merger Sub merged with and into Inphi with Inphi as the surviving corporation and a wholly owned subsidiary of Holdco (the "Delaware Merger" and, together with the Bermuda Merger, the "Mergers"). At the effective time of the Mergers, the restricted stock units that vest based on the per share market value of the shares of Inphi Common Stock (the "Inphi Common Stock") exceeding certain relative performance target levels (a "MVSU") were vested in full on April 20, 2020. The holder of such vested MVSUs became entitled to receive (subject to applicable withholding or other taxes) (i) an amount in cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU, and (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 14:06 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 168 | $168.00 | $28,224.00 |
DisclosureSEC source: 0001437749-21-007414 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,992 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:15 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 13,582 | $154.40 | $2,097,060.80 |
DisclosureSEC source: 0001437749-21-005769 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,160 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:15 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 28,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-005769 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,742 F1 · price: These shares were received for no consideration upon the satisfaction of certain performance-vesting criteria underlying an award approved in January 2018, pursuant to a determination by the Compensation Committee of the Board of Directors of Inphi Corporation of the achievement of the performance vesting rate at 225%, resulting in the payout of such awards at 225% of the target number of shares. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 17:24 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 977 | $168.52 | $164,644.04 |
DisclosureSEC source: 0001437749-21-004732 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,073 Read SEC document |
| February 24, 2021 Filed Mar 3, 2021 13:11 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 1,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004805 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,392 F2 · shares: The restricted stock units vest quarterly over a 1 year period, and the first quarterly vesting date is scheduled to occur on 3/25/2021. Read SEC document |
| February 24, 2021 Filed Mar 3, 2021 13:11 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 7,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004805 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,044 F1 · shares: The restricted stock units vest quarterly over a 3 year period, and the first quarterly vesting date is scheduled to occur on 6/1/2021. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 14:50 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 9,371 | $160.47 | $1,503,764.37 |
DisclosureSEC source: 0001437749-21-000105 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,050 Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 14:50 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 18,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-000105 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,421 F1 · price: These shares were received for no consideration upon the satisfaction of certain performance-vesting criteria underlying an award approved in January 2018, pursuant to a determination by the Compensation Committee of the Board of Directors of Inphi Corporation to end the performance period on December 31, 2020 and approve payout at the maximum level of achievement for a specified percentage of the award based on the substantial certainty of performance through the end of the original performance period in 2021 (as previously disclosed in the joint proxy statement/prospectus of Inphi Corporation and Marvell Technology Group Ltd. filed on Form S-4 on December 22, 2020). Read SEC document |
| December 23, 2020 Filed Dec 29, 2020 12:19 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 208 | $158.74 | $33,017.92 |
DisclosureSEC source: 0001437749-20-026033 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,521 Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 23:25 UTC | Amesite Inc. AMST · Entity 8151 | PurchaseCommon Stock | 4,000 | $5.00 | $20,000.00 |
DisclosureSEC source: 0001213900-20-028989 · ownership.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,666 Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 17:28 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 208 | $106.87 | $22,228.96 |
DisclosureSEC source: 0001437749-20-020283 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,729 Read SEC document |
| June 23, 2020 Filed Jul 13, 2020 12:02 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 208 | $114.08 | $23,728.64 |
DisclosureSEC source: 0001437749-20-015052 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,937 F1 · kind: This transfer was made to satisfy tax withholding obligations of the reporting person in connection with the vesting of restricted stock. Read SEC document |
| April 27, 2020 Filed Apr 27, 2020 19:51 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 1,046 | $99.67 | $104,253.36 |
DisclosureSEC source: 0001437749-20-008612 · rdgdoc.xml · nonDerivative · entry 3 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,145 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, which became effective on 11/19/2019. F3 · price: The sale reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.33 to $100.14. Read SEC document |
| April 27, 2020 Filed Apr 27, 2020 19:51 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 943 | $98.87 | $93,238.75 |
DisclosureSEC source: 0001437749-20-008612 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,191 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, which became effective on 11/19/2019. F2 · price: Represents the weighted average sales price for a number of transactions effected at prices ranging from $98.32 to $99.27. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 19:51 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 1,957 | $98.75 | $193,253.75 |
DisclosureSEC source: 0001437749-20-008612 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,134 Read SEC document |
| April 21, 2020 Filed Apr 22, 2020 17:37 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 1,271 | $97.29 | $123,656.99 |
DisclosureSEC source: 0001437749-20-008239 · rdgdoc.xml · nonDerivative · entry 4 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,091 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, which became effective on 11/19/2019. F5 · price: The sale reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.845 to $97.81. Read SEC document |
| April 21, 2020 Filed Apr 22, 2020 17:37 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 4,567 | $96.31 | $439,843.20 |
DisclosureSEC source: 0001437749-20-008239 · rdgdoc.xml · nonDerivative · entry 3 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,362 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, which became effective on 11/19/2019. F4 · price: The sale reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.82 to $96.81. Read SEC document |
| April 21, 2020 Filed Apr 22, 2020 17:37 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 1,300 | $94.49 | $122,842.98 |
DisclosureSEC source: 0001437749-20-008239 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,929 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, which became effective on 11/19/2019. F3 · price: Represents the weighted average sales price for a number of transactions effected at prices ranging from $93.95 to $94.91. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 and 5 to this Form 4. Read SEC document |
| April 20, 2020 Filed Apr 21, 2020 14:06 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 1,967 | $96.88 | $190,562.96 |
DisclosureSEC source: 0001437749-20-008108 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,773 Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 17:37 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 456 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-008239 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,229 F1 · shares: The restricted stock unit vests as to 25% of the shares on each of 4/20/2021, 4/20/2022, 4/20/2023 and 4/20/2024. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 14:06 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 2,915 | $96.13 | $280,218.95 |
DisclosureSEC source: 0001437749-20-008108 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,740 Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 13:30 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 172 | $58.81 | $10,115.32 |
DisclosureSEC source: 0001437749-20-005993 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,655 Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 18:35 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 1,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003197 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,827 F2 · shares: The restricted stock units vest as to 25% of the shares on each of 3/23/2020, 6/23/2020, 9/23/2020, and 12/23/2020. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 18:35 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 10,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003197 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,153 F1 · shares: The restricted stock units vest as to 25% of the shares on each of 3/1/2021, 3/1/2022, 3/1/2023, and 3/1/2024. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 14:59 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 2,336 | $73.49 | $171,672.64 |
DisclosureSEC source: 0001437749-19-024705 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,292 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, which became effective on 11/19/2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.